A Comparative Assessment of MR BI-RADS 4 Breast Lesions With Kaiser Score and Apparent Diffusion Coefficient Value

• Published in: Frontiers in oncology Vol. 11; p. 779642
• Main Authors: Meng, Lingsong, Zhao, Xin, Lu, Lin, Xing, Qingna, Wang, Kaiyu, Guo, Yafei, Shang, Honglei, Chen, Yan, Huang, Mengyue, Sun, Yongbing, Zhang, Xiaoan
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 02-12-2021
• Subjects: apparent diffusion coefficient; BI-RADS; breast cancer; Kaiser score; Oncology; specificity; specificity; apparent diffusion coefficient; BI-RADS; breast cancer; Kaiser score
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2021.779642

To investigate the diagnostic performance of the Kaiser score and apparent diffusion coefficient (ADC) to differentiate Breast Imaging Reporting and Data System (BI-RADS) Category 4 lesions at dynamic contrast-enhanced (DCE) MRI.
This was a single-institution retrospective study of patients who underwent breast MRI from March 2020 to June 2021. All image data were acquired with a 3-T MRI system. Kaiser score of each lesion was assigned by an experienced breast radiologist. Kaiser score+ was determined by combining ADC and Kaiser score. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of Kaiser score+, Kaiser score, and ADC. The area under the curve (AUC) values were calculated and compared by using the Delong test. The differences in sensitivity and specificity between different indicators were determined by the McNemar test.
The study involved 243 women (mean age, 43.1 years; age range, 18-67 years) with 268 MR BI-RADS 4 lesions. Overall diagnostic performance for Kaiser score (AUC, 0.902) was significantly higher than for ADC (AUC, 0.81;
= 0.004). There were no significant differences in AUCs between Kaiser score and Kaiser score+ (
= 0.134). The Kaiser score was superior to ADC in avoiding unnecessary biopsies (
< 0.001). Compared with the Kaiser score alone, the specificity of Kaiser score+ increased by 7.82%, however, at the price of a lower sensitivity.
For MR BI-RADS category 4 breast lesions, the Kaiser score was superior to ADC mapping regarding the potential to avoid unnecessary biopsies. However, the combination of both indicators did not significantly contribute to breast cancer diagnosis of this subgroup.